nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ABCB1—kidney cancer	0.11	1	CbGaD
Phenytoin—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0382	0.0659	CbGbCtD
Phenytoin—CYP3A7—Temsirolimus—kidney cancer	0.0382	0.0659	CbGbCtD
Phenytoin—CYP3A5—Temsirolimus—kidney cancer	0.0287	0.0494	CbGbCtD
Phenytoin—ABCC2—Paclitaxel—kidney cancer	0.0196	0.0339	CbGbCtD
Phenytoin—ABCB1—Temsirolimus—kidney cancer	0.0187	0.0322	CbGbCtD
Phenytoin—ABCC2—Sorafenib—kidney cancer	0.0174	0.0301	CbGbCtD
Phenytoin—ABCC2—Vinblastine—kidney cancer	0.0172	0.0297	CbGbCtD
Phenytoin—ABCC2—Vincristine—kidney cancer	0.0169	0.0292	CbGbCtD
Phenytoin—CYP3A4—Everolimus—kidney cancer	0.0166	0.0285	CbGbCtD
Phenytoin—CYP2C8—Pazopanib—kidney cancer	0.0145	0.025	CbGbCtD
Phenytoin—ABCC2—Sunitinib—kidney cancer	0.0141	0.0244	CbGbCtD
Phenytoin—ALB—Erlotinib—kidney cancer	0.0134	0.023	CbGbCtD
Phenytoin—CYP3A7—Paclitaxel—kidney cancer	0.0131	0.0226	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0131	0.0226	CbGbCtD
Phenytoin—CYP3A7—Sorafenib—kidney cancer	0.0117	0.0201	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0117	0.0201	CbGbCtD
Phenytoin—CYP3A7—Vincristine—kidney cancer	0.0113	0.0195	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0113	0.0195	CbGbCtD
Phenytoin—CYP3A4—Temsirolimus—kidney cancer	0.0112	0.0193	CbGbCtD
Phenytoin—CYP2B6—Sorafenib—kidney cancer	0.0111	0.0191	CbGbCtD
Phenytoin—CYP3A5—Erlotinib—kidney cancer	0.0107	0.0185	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—kidney cancer	0.0106	0.0182	CbGbCtD
Phenytoin—CYP2C9—Capecitabine—kidney cancer	0.0105	0.0182	CbGbCtD
Phenytoin—CYP2C8—Erlotinib—kidney cancer	0.0103	0.0178	CbGbCtD
Phenytoin—CYP3A5—Paclitaxel—kidney cancer	0.00984	0.017	CbGbCtD
Phenytoin—ABCB1—Pazopanib—kidney cancer	0.0098	0.0169	CbGbCtD
Phenytoin—CYP2C8—Paclitaxel—kidney cancer	0.00946	0.0163	CbGbCtD
Phenytoin—CYP3A7—Sunitinib—kidney cancer	0.00944	0.0163	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00944	0.0163	CbGbCtD
Phenytoin—ABCB1—Dactinomycin—kidney cancer	0.00897	0.0155	CbGbCtD
Phenytoin—CYP3A5—Sorafenib—kidney cancer	0.00874	0.0151	CbGbCtD
Phenytoin—CYP3A5—Vincristine—kidney cancer	0.00848	0.0146	CbGbCtD
Phenytoin—CYP2C8—Sorafenib—kidney cancer	0.0084	0.0145	CbGbCtD
Phenytoin—ABCB1—Gemcitabine—kidney cancer	0.00709	0.0122	CbGbCtD
Phenytoin—CYP3A5—Sunitinib—kidney cancer	0.00708	0.0122	CbGbCtD
Phenytoin—CYP2C19—Sorafenib—kidney cancer	0.00705	0.0122	CbGbCtD
Phenytoin—ABCB1—Erlotinib—kidney cancer	0.007	0.0121	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—kidney cancer	0.00673	0.0116	CbGbCtD
Phenytoin—CYP2C9—Paclitaxel—kidney cancer	0.0066	0.0114	CbGbCtD
Phenytoin—ABCB1—Paclitaxel—kidney cancer	0.0064	0.011	CbGbCtD
Phenytoin—CYP3A4—Pazopanib—kidney cancer	0.00587	0.0101	CbGbCtD
Phenytoin—CYP2C9—Sorafenib—kidney cancer	0.00586	0.0101	CbGbCtD
Phenytoin—ABCB1—Sorafenib—kidney cancer	0.00569	0.0098	CbGbCtD
Phenytoin—ABCB1—Vinblastine—kidney cancer	0.00562	0.00968	CbGbCtD
Phenytoin—ABCB1—Vincristine—kidney cancer	0.00552	0.00952	CbGbCtD
Phenytoin—ABCB1—Sunitinib—kidney cancer	0.00461	0.00794	CbGbCtD
Phenytoin—CYP3A4—Erlotinib—kidney cancer	0.00419	0.00722	CbGbCtD
Phenytoin—CYP3A4—Paclitaxel—kidney cancer	0.00384	0.00661	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—kidney cancer	0.00345	0.00595	CbGbCtD
Phenytoin—CYP3A4—Sorafenib—kidney cancer	0.00341	0.00587	CbGbCtD
Phenytoin—CYP3A4—Vinblastine—kidney cancer	0.00337	0.0058	CbGbCtD
Phenytoin—CYP3A4—Vincristine—kidney cancer	0.00331	0.0057	CbGbCtD
Phenytoin—CYP3A4—Sunitinib—kidney cancer	0.00276	0.00476	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—kidney cancer	0.00207	0.00356	CbGbCtD
Phenytoin—CYP2C19—urine—kidney cancer	0.00194	0.0857	CbGeAlD
Phenytoin—CYP2C9—urine—kidney cancer	0.00151	0.0665	CbGeAlD
Phenytoin—SCN9A—nephron tubule—kidney cancer	0.00117	0.0517	CbGeAlD
Phenytoin—CYP3A4—urine—kidney cancer	0.00115	0.0507	CbGeAlD
Phenytoin—SLCO1C1—renal system—kidney cancer	0.00103	0.0457	CbGeAlD
Phenytoin—SLCO1C1—kidney—kidney cancer	0.001	0.0441	CbGeAlD
Phenytoin—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000995	0.0439	CbGeAlD
Phenytoin—SCN4A—renal system—kidney cancer	0.000951	0.042	CbGeAlD
Phenytoin—SCN4A—kidney—kidney cancer	0.000919	0.0406	CbGeAlD
Phenytoin—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000851	0.0376	CbGeAlD
Phenytoin—SCN2A—cortex of kidney—kidney cancer	0.000792	0.035	CbGeAlD
Phenytoin—SCN3A—renal system—kidney cancer	0.000739	0.0326	CbGeAlD
Phenytoin—SCN3A—kidney—kidney cancer	0.000715	0.0315	CbGeAlD
Phenytoin—SCN3A—cortex of kidney—kidney cancer	0.000696	0.0307	CbGeAlD
Phenytoin—SCN5A—cardiac atrium—kidney cancer	0.00066	0.0291	CbGeAlD
Phenytoin—ABCC2—nephron tubule—kidney cancer	0.000608	0.0268	CbGeAlD
Phenytoin—ABCC2—renal system—kidney cancer	0.000553	0.0244	CbGeAlD
Phenytoin—ABCC2—kidney—kidney cancer	0.000535	0.0236	CbGeAlD
Phenytoin—ABCC2—cortex of kidney—kidney cancer	0.000521	0.023	CbGeAlD
Phenytoin—CYP2C8—renal system—kidney cancer	0.000415	0.0183	CbGeAlD
Phenytoin—CYP3A5—nephron tubule—kidney cancer	0.000412	0.0182	CbGeAlD
Phenytoin—CYP2B6—nephron tubule—kidney cancer	0.000409	0.0181	CbGeAlD
Phenytoin—CYP2C8—kidney—kidney cancer	0.000401	0.0177	CbGeAlD
Phenytoin—Oxaprozin—PTGS1—kidney cancer	0.000392	0.228	CrCbGaD
Phenytoin—CYP3A5—renal system—kidney cancer	0.000374	0.0165	CbGeAlD
Phenytoin—CYP2B6—renal system—kidney cancer	0.000372	0.0164	CbGeAlD
Phenytoin—CYP3A5—kidney—kidney cancer	0.000362	0.016	CbGeAlD
Phenytoin—CYP2B6—kidney—kidney cancer	0.00036	0.0159	CbGeAlD
Phenytoin—CYP3A5—cortex of kidney—kidney cancer	0.000352	0.0156	CbGeAlD
Phenytoin—CYP2B6—gonad—kidney cancer	0.000334	0.0147	CbGeAlD
Phenytoin—CYP3A4—renal system—kidney cancer	0.000281	0.0124	CbGeAlD
Phenytoin—CYP3A4—kidney—kidney cancer	0.000272	0.012	CbGeAlD
Phenytoin—Phenylbutazone—PTGS1—kidney cancer	0.000259	0.15	CrCbGaD
Phenytoin—Warfarin—CYP1A1—kidney cancer	0.000226	0.132	CrCbGaD
Phenytoin—Oxaprozin—PTGS2—kidney cancer	0.000224	0.13	CrCbGaD
Phenytoin—ABCB1—nephron tubule—kidney cancer	0.000219	0.00965	CbGeAlD
Phenytoin—ABCB1—renal system—kidney cancer	0.000199	0.00878	CbGeAlD
Phenytoin—ABCB1—kidney—kidney cancer	0.000192	0.00848	CbGeAlD
Phenytoin—ABCB1—cortex of kidney—kidney cancer	0.000187	0.00826	CbGeAlD
Phenytoin—ABCB1—gonad—kidney cancer	0.000178	0.00787	CbGeAlD
Phenytoin—Phenobarbital—CYP1A1—kidney cancer	0.000158	0.0916	CrCbGaD
Phenytoin—Phenylbutazone—PTGS2—kidney cancer	0.000148	0.086	CrCbGaD
Phenytoin—Diphenhydramine—PTGS1—kidney cancer	0.000141	0.0818	CrCbGaD
Phenytoin—Carbamazepine—ABCB1—kidney cancer	9e-05	0.0522	CrCbGaD
Phenytoin—Phenobarbital—ABCB1—kidney cancer	8.38e-05	0.0487	CrCbGaD
Phenytoin—Diplopia—Doxorubicin—kidney cancer	7.55e-05	0.000383	CcSEcCtD
Phenytoin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	7.55e-05	0.000383	CcSEcCtD
Phenytoin—Paraesthesia—Gemcitabine—kidney cancer	7.52e-05	0.000381	CcSEcCtD
Phenytoin—Cough—Paclitaxel—kidney cancer	7.5e-05	0.00038	CcSEcCtD
Phenytoin—Asthenia—Sunitinib—kidney cancer	7.49e-05	0.00038	CcSEcCtD
Phenytoin—Dyspnoea—Gemcitabine—kidney cancer	7.47e-05	0.000379	CcSEcCtD
Phenytoin—Nausea—Vinblastine—kidney cancer	7.46e-05	0.000378	CcSEcCtD
Phenytoin—Somnolence—Gemcitabine—kidney cancer	7.45e-05	0.000377	CcSEcCtD
Phenytoin—Convulsion—Paclitaxel—kidney cancer	7.45e-05	0.000377	CcSEcCtD
Phenytoin—Migraine—Doxorubicin—kidney cancer	7.43e-05	0.000377	CcSEcCtD
Phenytoin—Affect lability—Doxorubicin—kidney cancer	7.43e-05	0.000377	CcSEcCtD
Phenytoin—Nausea—Everolimus—kidney cancer	7.43e-05	0.000376	CcSEcCtD
Phenytoin—Diarrhoea—Sorafenib—kidney cancer	7.43e-05	0.000376	CcSEcCtD
Phenytoin—Hypertension—Paclitaxel—kidney cancer	7.42e-05	0.000376	CcSEcCtD
Phenytoin—Pruritus—Sunitinib—kidney cancer	7.39e-05	0.000374	CcSEcCtD
Phenytoin—Immune system disorder—Capecitabine—kidney cancer	7.32e-05	0.000371	CcSEcCtD
Phenytoin—Myalgia—Paclitaxel—kidney cancer	7.32e-05	0.000371	CcSEcCtD
Phenytoin—Chest pain—Paclitaxel—kidney cancer	7.32e-05	0.000371	CcSEcCtD
Phenytoin—Arthralgia—Paclitaxel—kidney cancer	7.32e-05	0.000371	CcSEcCtD
Phenytoin—Face oedema—Doxorubicin—kidney cancer	7.29e-05	0.000369	CcSEcCtD
Phenytoin—Decreased appetite—Gemcitabine—kidney cancer	7.28e-05	0.000369	CcSEcCtD
Phenytoin—Hypersensitivity—Dactinomycin—kidney cancer	7.28e-05	0.000369	CcSEcCtD
Phenytoin—Chills—Capecitabine—kidney cancer	7.27e-05	0.000368	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.23e-05	0.000367	CcSEcCtD
Phenytoin—Discomfort—Paclitaxel—kidney cancer	7.23e-05	0.000366	CcSEcCtD
Phenytoin—Fatigue—Gemcitabine—kidney cancer	7.22e-05	0.000366	CcSEcCtD
Phenytoin—Cardiac arrest—Doxorubicin—kidney cancer	7.18e-05	0.000364	CcSEcCtD
Phenytoin—Dizziness—Sorafenib—kidney cancer	7.18e-05	0.000364	CcSEcCtD
Phenytoin—Constipation—Gemcitabine—kidney cancer	7.17e-05	0.000363	CcSEcCtD
Phenytoin—Nausea—Erlotinib—kidney cancer	7.17e-05	0.000363	CcSEcCtD
Phenytoin—Dry mouth—Paclitaxel—kidney cancer	7.16e-05	0.000363	CcSEcCtD
Phenytoin—Mood swings—Doxorubicin—kidney cancer	7.15e-05	0.000362	CcSEcCtD
Phenytoin—Diarrhoea—Sunitinib—kidney cancer	7.15e-05	0.000362	CcSEcCtD
Phenytoin—Ataxia—Doxorubicin—kidney cancer	7.1e-05	0.00036	CcSEcCtD
Phenytoin—Asthenia—Dactinomycin—kidney cancer	7.09e-05	0.000359	CcSEcCtD
Phenytoin—Confusional state—Paclitaxel—kidney cancer	7.07e-05	0.000358	CcSEcCtD
Phenytoin—Dehydration—Doxorubicin—kidney cancer	7.02e-05	0.000356	CcSEcCtD
Phenytoin—Anaphylactic shock—Paclitaxel—kidney cancer	7.02e-05	0.000356	CcSEcCtD
Phenytoin—Body temperature increased—Vincristine—kidney cancer	6.98e-05	0.000354	CcSEcCtD
Phenytoin—Liver function test abnormal—Doxorubicin—kidney cancer	6.97e-05	0.000353	CcSEcCtD
Phenytoin—Infection—Paclitaxel—kidney cancer	6.97e-05	0.000353	CcSEcCtD
Phenytoin—Flatulence—Capecitabine—kidney cancer	6.95e-05	0.000352	CcSEcCtD
Phenytoin—Dysgeusia—Capecitabine—kidney cancer	6.91e-05	0.00035	CcSEcCtD
Phenytoin—Dizziness—Sunitinib—kidney cancer	6.91e-05	0.00035	CcSEcCtD
Phenytoin—Feeling abnormal—Gemcitabine—kidney cancer	6.91e-05	0.00035	CcSEcCtD
Phenytoin—Shock—Paclitaxel—kidney cancer	6.9e-05	0.00035	CcSEcCtD
Phenytoin—Vomiting—Sorafenib—kidney cancer	6.9e-05	0.00035	CcSEcCtD
Phenytoin—Orthostatic hypotension—Doxorubicin—kidney cancer	6.9e-05	0.000349	CcSEcCtD
Phenytoin—Abdominal pain upper—Doxorubicin—kidney cancer	6.9e-05	0.000349	CcSEcCtD
Phenytoin—Nervous system disorder—Paclitaxel—kidney cancer	6.88e-05	0.000349	CcSEcCtD
Phenytoin—Hypokalaemia—Doxorubicin—kidney cancer	6.87e-05	0.000348	CcSEcCtD
Phenytoin—Thrombocytopenia—Paclitaxel—kidney cancer	6.87e-05	0.000348	CcSEcCtD
Phenytoin—Tachycardia—Paclitaxel—kidney cancer	6.85e-05	0.000347	CcSEcCtD
Phenytoin—Rash—Sorafenib—kidney cancer	6.84e-05	0.000347	CcSEcCtD
Phenytoin—Dermatitis—Sorafenib—kidney cancer	6.84e-05	0.000346	CcSEcCtD
Phenytoin—Back pain—Capecitabine—kidney cancer	6.82e-05	0.000346	CcSEcCtD
Phenytoin—Breast disorder—Doxorubicin—kidney cancer	6.82e-05	0.000346	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.8e-05	0.000345	CcSEcCtD
Phenytoin—Headache—Sorafenib—kidney cancer	6.8e-05	0.000345	CcSEcCtD
Phenytoin—Muscle spasms—Capecitabine—kidney cancer	6.78e-05	0.000344	CcSEcCtD
Phenytoin—Hyperhidrosis—Paclitaxel—kidney cancer	6.78e-05	0.000344	CcSEcCtD
Phenytoin—Diarrhoea—Dactinomycin—kidney cancer	6.76e-05	0.000343	CcSEcCtD
Phenytoin—Anorexia—Paclitaxel—kidney cancer	6.69e-05	0.000339	CcSEcCtD
Phenytoin—Gastritis—Doxorubicin—kidney cancer	6.68e-05	0.000339	CcSEcCtD
Phenytoin—Muscular weakness—Doxorubicin—kidney cancer	6.66e-05	0.000337	CcSEcCtD
Phenytoin—Vomiting—Sunitinib—kidney cancer	6.64e-05	0.000336	CcSEcCtD
Phenytoin—Body temperature increased—Gemcitabine—kidney cancer	6.62e-05	0.000336	CcSEcCtD
Phenytoin—Tremor—Capecitabine—kidney cancer	6.61e-05	0.000335	CcSEcCtD
Phenytoin—Rash—Sunitinib—kidney cancer	6.58e-05	0.000334	CcSEcCtD
Phenytoin—Dermatitis—Sunitinib—kidney cancer	6.58e-05	0.000333	CcSEcCtD
Phenytoin—Hypotension—Paclitaxel—kidney cancer	6.56e-05	0.000332	CcSEcCtD
Phenytoin—Ill-defined disorder—Capecitabine—kidney cancer	6.55e-05	0.000332	CcSEcCtD
Phenytoin—Headache—Sunitinib—kidney cancer	6.54e-05	0.000332	CcSEcCtD
Phenytoin—Influenza—Doxorubicin—kidney cancer	6.53e-05	0.000331	CcSEcCtD
Phenytoin—Asthma—Doxorubicin—kidney cancer	6.53e-05	0.000331	CcSEcCtD
Phenytoin—Dysphagia—Doxorubicin—kidney cancer	6.53e-05	0.000331	CcSEcCtD
Phenytoin—Anaemia—Capecitabine—kidney cancer	6.52e-05	0.00033	CcSEcCtD
Phenytoin—Hypersensitivity—Vincristine—kidney cancer	6.51e-05	0.00033	CcSEcCtD
Phenytoin—Eosinophilia—Doxorubicin—kidney cancer	6.46e-05	0.000327	CcSEcCtD
Phenytoin—Nausea—Sorafenib—kidney cancer	6.45e-05	0.000327	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.39e-05	0.000324	CcSEcCtD
Phenytoin—Malaise—Capecitabine—kidney cancer	6.36e-05	0.000322	CcSEcCtD
Phenytoin—Insomnia—Paclitaxel—kidney cancer	6.35e-05	0.000322	CcSEcCtD
Phenytoin—Vertigo—Capecitabine—kidney cancer	6.34e-05	0.000321	CcSEcCtD
Phenytoin—Asthenia—Vincristine—kidney cancer	6.34e-05	0.000321	CcSEcCtD
Phenytoin—Syncope—Capecitabine—kidney cancer	6.33e-05	0.000321	CcSEcCtD
Phenytoin—Leukopenia—Capecitabine—kidney cancer	6.31e-05	0.00032	CcSEcCtD
Phenytoin—Paraesthesia—Paclitaxel—kidney cancer	6.3e-05	0.000319	CcSEcCtD
Phenytoin—Vomiting—Dactinomycin—kidney cancer	6.29e-05	0.000319	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—kidney cancer	6.28e-05	0.000318	CcSEcCtD
Phenytoin—Dyspnoea—Paclitaxel—kidney cancer	6.26e-05	0.000317	CcSEcCtD
Phenytoin—Somnolence—Paclitaxel—kidney cancer	6.24e-05	0.000316	CcSEcCtD
Phenytoin—Palpitations—Capecitabine—kidney cancer	6.23e-05	0.000316	CcSEcCtD
Phenytoin—Rash—Dactinomycin—kidney cancer	6.23e-05	0.000316	CcSEcCtD
Phenytoin—Nausea—Sunitinib—kidney cancer	6.2e-05	0.000314	CcSEcCtD
Phenytoin—Loss of consciousness—Capecitabine—kidney cancer	6.2e-05	0.000314	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—kidney cancer	6.2e-05	0.000314	CcSEcCtD
Phenytoin—Dyspepsia—Paclitaxel—kidney cancer	6.18e-05	0.000313	CcSEcCtD
Phenytoin—Cough—Capecitabine—kidney cancer	6.16e-05	0.000312	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—kidney cancer	6.1e-05	0.000309	CcSEcCtD
Phenytoin—Decreased appetite—Paclitaxel—kidney cancer	6.1e-05	0.000309	CcSEcCtD
Phenytoin—Hypertension—Capecitabine—kidney cancer	6.09e-05	0.000309	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.06e-05	0.000307	CcSEcCtD
Phenytoin—Fatigue—Paclitaxel—kidney cancer	6.05e-05	0.000306	CcSEcCtD
Phenytoin—Diarrhoea—Vincristine—kidney cancer	6.04e-05	0.000306	CcSEcCtD
Phenytoin—Asthenia—Gemcitabine—kidney cancer	6.01e-05	0.000305	CcSEcCtD
Phenytoin—Chest pain—Capecitabine—kidney cancer	6.01e-05	0.000304	CcSEcCtD
Phenytoin—Myalgia—Capecitabine—kidney cancer	6.01e-05	0.000304	CcSEcCtD
Phenytoin—Arthralgia—Capecitabine—kidney cancer	6.01e-05	0.000304	CcSEcCtD
Phenytoin—Constipation—Paclitaxel—kidney cancer	6e-05	0.000304	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—kidney cancer	5.96e-05	0.000302	CcSEcCtD
Phenytoin—Discomfort—Capecitabine—kidney cancer	5.93e-05	0.000301	CcSEcCtD
Phenytoin—Pruritus—Gemcitabine—kidney cancer	5.93e-05	0.0003	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—kidney cancer	5.9e-05	0.000299	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—kidney cancer	5.89e-05	0.000298	CcSEcCtD
Phenytoin—Dry mouth—Capecitabine—kidney cancer	5.87e-05	0.000298	CcSEcCtD
Phenytoin—Nausea—Dactinomycin—kidney cancer	5.87e-05	0.000298	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—kidney cancer	5.85e-05	0.000297	CcSEcCtD
Phenytoin—Dizziness—Vincristine—kidney cancer	5.84e-05	0.000296	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—kidney cancer	5.82e-05	0.000295	CcSEcCtD
Phenytoin—Confusional state—Capecitabine—kidney cancer	5.81e-05	0.000294	CcSEcCtD
Phenytoin—Feeling abnormal—Paclitaxel—kidney cancer	5.78e-05	0.000293	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.77e-05	0.000292	CcSEcCtD
Phenytoin—Diarrhoea—Gemcitabine—kidney cancer	5.73e-05	0.000291	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—kidney cancer	5.72e-05	0.00029	CcSEcCtD
Phenytoin—Infection—Capecitabine—kidney cancer	5.72e-05	0.00029	CcSEcCtD
Phenytoin—Shock—Capecitabine—kidney cancer	5.66e-05	0.000287	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—kidney cancer	5.66e-05	0.000287	CcSEcCtD
Phenytoin—Nervous system disorder—Capecitabine—kidney cancer	5.65e-05	0.000286	CcSEcCtD
Phenytoin—Thrombocytopenia—Capecitabine—kidney cancer	5.64e-05	0.000286	CcSEcCtD
Phenytoin—Tachycardia—Capecitabine—kidney cancer	5.62e-05	0.000285	CcSEcCtD
Phenytoin—Vomiting—Vincristine—kidney cancer	5.62e-05	0.000285	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—kidney cancer	5.58e-05	0.000283	CcSEcCtD
Phenytoin—Urticaria—Paclitaxel—kidney cancer	5.57e-05	0.000282	CcSEcCtD
Phenytoin—Rash—Vincristine—kidney cancer	5.57e-05	0.000282	CcSEcCtD
Phenytoin—Hyperhidrosis—Capecitabine—kidney cancer	5.57e-05	0.000282	CcSEcCtD
Phenytoin—Dermatitis—Vincristine—kidney cancer	5.56e-05	0.000282	CcSEcCtD
Phenytoin—Body temperature increased—Paclitaxel—kidney cancer	5.55e-05	0.000281	CcSEcCtD
Phenytoin—Headache—Vincristine—kidney cancer	5.53e-05	0.00028	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—kidney cancer	5.5e-05	0.000279	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—kidney cancer	5.49e-05	0.000278	CcSEcCtD
Phenytoin—Anorexia—Capecitabine—kidney cancer	5.49e-05	0.000278	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—kidney cancer	5.46e-05	0.000277	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—kidney cancer	5.43e-05	0.000275	CcSEcCtD
Phenytoin—Hypotension—Capecitabine—kidney cancer	5.38e-05	0.000273	CcSEcCtD
Phenytoin—Vomiting—Gemcitabine—kidney cancer	5.33e-05	0.00027	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—kidney cancer	5.32e-05	0.000269	CcSEcCtD
Phenytoin—Rash—Gemcitabine—kidney cancer	5.28e-05	0.000268	CcSEcCtD
Phenytoin—Dermatitis—Gemcitabine—kidney cancer	5.28e-05	0.000267	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—kidney cancer	5.25e-05	0.000266	CcSEcCtD
Phenytoin—Headache—Gemcitabine—kidney cancer	5.25e-05	0.000266	CcSEcCtD
Phenytoin—Nausea—Vincristine—kidney cancer	5.25e-05	0.000266	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.25e-05	0.000266	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—kidney cancer	5.24e-05	0.000265	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—kidney cancer	5.22e-05	0.000265	CcSEcCtD
Phenytoin—Insomnia—Capecitabine—kidney cancer	5.21e-05	0.000264	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—kidney cancer	5.2e-05	0.000263	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—kidney cancer	5.18e-05	0.000263	CcSEcCtD
Phenytoin—Paraesthesia—Capecitabine—kidney cancer	5.17e-05	0.000262	CcSEcCtD
Phenytoin—Hypersensitivity—Paclitaxel—kidney cancer	5.17e-05	0.000262	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—kidney cancer	5.13e-05	0.00026	CcSEcCtD
Phenytoin—Dyspnoea—Capecitabine—kidney cancer	5.13e-05	0.00026	CcSEcCtD
Phenytoin—Dyspepsia—Capecitabine—kidney cancer	5.07e-05	0.000257	CcSEcCtD
Phenytoin—Asthenia—Paclitaxel—kidney cancer	5.03e-05	0.000255	CcSEcCtD
Phenytoin—Decreased appetite—Capecitabine—kidney cancer	5.01e-05	0.000254	CcSEcCtD
Phenytoin—Nausea—Gemcitabine—kidney cancer	4.98e-05	0.000252	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Capecitabine—kidney cancer	4.97e-05	0.000252	CcSEcCtD
Phenytoin—Fatigue—Capecitabine—kidney cancer	4.96e-05	0.000252	CcSEcCtD
Phenytoin—Pruritus—Paclitaxel—kidney cancer	4.96e-05	0.000252	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—kidney cancer	4.94e-05	0.00025	CcSEcCtD
Phenytoin—Constipation—Capecitabine—kidney cancer	4.92e-05	0.000249	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—kidney cancer	4.87e-05	0.000247	CcSEcCtD
Phenytoin—Diarrhoea—Paclitaxel—kidney cancer	4.8e-05	0.000243	CcSEcCtD
Phenytoin—Feeling abnormal—Capecitabine—kidney cancer	4.74e-05	0.00024	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—kidney cancer	4.72e-05	0.000239	CcSEcCtD
Phenytoin—Chills—Doxorubicin—kidney cancer	4.69e-05	0.000238	CcSEcCtD
Phenytoin—Dizziness—Paclitaxel—kidney cancer	4.64e-05	0.000235	CcSEcCtD
Phenytoin—Urticaria—Capecitabine—kidney cancer	4.57e-05	0.000232	CcSEcCtD
Phenytoin—Body temperature increased—Capecitabine—kidney cancer	4.55e-05	0.000231	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—kidney cancer	4.48e-05	0.000227	CcSEcCtD
Phenytoin—Tension—Doxorubicin—kidney cancer	4.46e-05	0.000226	CcSEcCtD
Phenytoin—Vomiting—Paclitaxel—kidney cancer	4.46e-05	0.000226	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—kidney cancer	4.45e-05	0.000226	CcSEcCtD
Phenytoin—Rash—Paclitaxel—kidney cancer	4.42e-05	0.000224	CcSEcCtD
Phenytoin—Dermatitis—Paclitaxel—kidney cancer	4.42e-05	0.000224	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—kidney cancer	4.42e-05	0.000224	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—kidney cancer	4.4e-05	0.000223	CcSEcCtD
Phenytoin—Headache—Paclitaxel—kidney cancer	4.4e-05	0.000223	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—kidney cancer	4.37e-05	0.000222	CcSEcCtD
Phenytoin—Hypersensitivity—Capecitabine—kidney cancer	4.24e-05	0.000215	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—kidney cancer	4.22e-05	0.000214	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—kidney cancer	4.2e-05	0.000213	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—kidney cancer	4.18e-05	0.000212	CcSEcCtD
Phenytoin—Nausea—Paclitaxel—kidney cancer	4.17e-05	0.000211	CcSEcCtD
Phenytoin—Asthenia—Capecitabine—kidney cancer	4.13e-05	0.000209	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—kidney cancer	4.1e-05	0.000208	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—kidney cancer	4.09e-05	0.000207	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—kidney cancer	4.08e-05	0.000207	CcSEcCtD
Phenytoin—Pruritus—Capecitabine—kidney cancer	4.07e-05	0.000206	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—kidney cancer	4.07e-05	0.000206	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—kidney cancer	4.02e-05	0.000204	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—kidney cancer	4e-05	0.000203	CcSEcCtD
Phenytoin—Cough—Doxorubicin—kidney cancer	3.97e-05	0.000201	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—kidney cancer	3.94e-05	0.0002	CcSEcCtD
Phenytoin—Diarrhoea—Capecitabine—kidney cancer	3.94e-05	0.0002	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—kidney cancer	3.93e-05	0.000199	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—kidney cancer	3.87e-05	0.000196	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—kidney cancer	3.87e-05	0.000196	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—kidney cancer	3.87e-05	0.000196	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—kidney cancer	3.83e-05	0.000194	CcSEcCtD
Phenytoin—Dizziness—Capecitabine—kidney cancer	3.81e-05	0.000193	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—kidney cancer	3.79e-05	0.000192	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—kidney cancer	3.74e-05	0.00019	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—kidney cancer	3.71e-05	0.000188	CcSEcCtD
Phenytoin—Infection—Doxorubicin—kidney cancer	3.69e-05	0.000187	CcSEcCtD
Phenytoin—Vomiting—Capecitabine—kidney cancer	3.66e-05	0.000185	CcSEcCtD
Phenytoin—Shock—Doxorubicin—kidney cancer	3.65e-05	0.000185	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—kidney cancer	3.64e-05	0.000184	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—kidney cancer	3.63e-05	0.000184	CcSEcCtD
Phenytoin—Rash—Capecitabine—kidney cancer	3.63e-05	0.000184	CcSEcCtD
Phenytoin—Dermatitis—Capecitabine—kidney cancer	3.63e-05	0.000184	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—kidney cancer	3.62e-05	0.000184	CcSEcCtD
Phenytoin—Headache—Capecitabine—kidney cancer	3.61e-05	0.000183	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—kidney cancer	3.59e-05	0.000182	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—kidney cancer	3.54e-05	0.000179	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—kidney cancer	3.47e-05	0.000176	CcSEcCtD
Phenytoin—Nausea—Capecitabine—kidney cancer	3.42e-05	0.000173	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.38e-05	0.000171	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—kidney cancer	3.36e-05	0.00017	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—kidney cancer	3.33e-05	0.000169	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—kidney cancer	3.31e-05	0.000168	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—kidney cancer	3.3e-05	0.000167	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—kidney cancer	3.27e-05	0.000166	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—kidney cancer	3.23e-05	0.000163	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.2e-05	0.000162	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—kidney cancer	3.2e-05	0.000162	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—kidney cancer	3.17e-05	0.000161	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—kidney cancer	3.06e-05	0.000155	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—kidney cancer	2.95e-05	0.000149	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—kidney cancer	2.93e-05	0.000149	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—kidney cancer	2.73e-05	0.000139	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—kidney cancer	2.66e-05	0.000135	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—kidney cancer	2.63e-05	0.000133	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—kidney cancer	2.54e-05	0.000129	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—kidney cancer	2.45e-05	0.000124	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—kidney cancer	2.36e-05	0.00012	CcSEcCtD
Phenytoin—Rash—Doxorubicin—kidney cancer	2.34e-05	0.000119	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—kidney cancer	2.34e-05	0.000118	CcSEcCtD
Phenytoin—Headache—Doxorubicin—kidney cancer	2.33e-05	0.000118	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—kidney cancer	2.2e-05	0.000112	CcSEcCtD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.07e-05	0.000122	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.07e-05	0.000122	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.07e-05	0.000122	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.07e-05	0.000122	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SCARB1—kidney cancer	1.07e-05	0.000122	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.06e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS1—kidney cancer	1.06e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CA2—kidney cancer	1.05e-05	0.00012	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.05e-05	0.000119	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.04e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PSMD7—kidney cancer	1.04e-05	0.000118	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.04e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—POMC—kidney cancer	1.03e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PGK1—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALAD—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.000117	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—LDHB—kidney cancer	1.01e-05	0.000115	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PGK1—kidney cancer	1e-05	0.000115	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC5A3—kidney cancer	1e-05	0.000115	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PDHB—kidney cancer	1e-05	0.000114	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1e-05	0.000114	CbGpPWpGaD
Phenytoin—CYP3A4—Biological oxidations—POMC—kidney cancer	9.99e-06	0.000114	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—LDHB—kidney cancer	9.85e-06	0.000112	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CRABP1—kidney cancer	9.85e-06	0.000112	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.85e-06	0.000112	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—BCHE—kidney cancer	9.83e-06	0.000112	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CA9—kidney cancer	9.81e-06	0.000112	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	9.79e-06	0.000112	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CA9—kidney cancer	9.75e-06	0.000111	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SLC5A5—kidney cancer	9.71e-06	0.000111	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CRABP1—kidney cancer	9.63e-06	0.00011	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.58e-06	0.000109	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.53e-06	0.000109	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	9.51e-06	0.000108	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CCBL1—kidney cancer	9.42e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PGK1—kidney cancer	9.39e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC5A3—kidney cancer	9.39e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SLC2A1—kidney cancer	9.38e-06	0.000107	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.37e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—LDHB—kidney cancer	9.2e-06	0.000105	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ITPR2—kidney cancer	9.16e-06	0.000104	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	9e-06	0.000103	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ITPR2—kidney cancer	8.95e-06	0.000102	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.86e-06	0.000101	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CA9—kidney cancer	8.75e-06	9.98e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.62e-06	9.82e-05	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	8.56e-06	9.76e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.55e-06	9.75e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CA9—kidney cancer	8.54e-06	9.74e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.43e-06	9.61e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ACHE—kidney cancer	8.35e-06	9.52e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTT1—kidney cancer	8.35e-06	9.52e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CRABP1—kidney cancer	8.34e-06	9.5e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CRABP1—kidney cancer	8.29e-06	9.45e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—kidney cancer	8.24e-06	9.39e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.17e-06	9.31e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPAT—kidney cancer	8.17e-06	9.31e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTT1—kidney cancer	8.16e-06	9.3e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ACHE—kidney cancer	8.16e-06	9.3e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CA9—kidney cancer	7.98e-06	9.1e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.96e-06	9.08e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SCARB1—kidney cancer	7.9e-06	9.01e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTP1—kidney cancer	7.83e-06	8.92e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS1—kidney cancer	7.82e-06	8.92e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.8e-06	8.89e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ITPR2—kidney cancer	7.75e-06	8.83e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SCARB1—kidney cancer	7.72e-06	8.8e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ITPR2—kidney cancer	7.71e-06	8.78e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PSMD7—kidney cancer	7.67e-06	8.74e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS1—kidney cancer	7.65e-06	8.72e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—POMC—kidney cancer	7.65e-06	8.71e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—FH—kidney cancer	7.59e-06	8.65e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—APRT—kidney cancer	7.59e-06	8.65e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PSMD7—kidney cancer	7.5e-06	8.55e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CRABP1—kidney cancer	7.44e-06	8.48e-05	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	7.43e-06	8.47e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ABCB1—kidney cancer	7.41e-06	8.44e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.32e-06	8.34e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—BCHE—kidney cancer	7.27e-06	8.29e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CRABP1—kidney cancer	7.26e-06	8.28e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTM1—kidney cancer	7.19e-06	8.2e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SLC5A5—kidney cancer	7.18e-06	8.19e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTEN—kidney cancer	7.18e-06	8.19e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.15e-06	8.14e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GPC3—kidney cancer	7.14e-06	8.14e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—BCHE—kidney cancer	7.11e-06	8.1e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.1e-06	8.1e-05	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.08e-06	8.07e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ACHE—kidney cancer	7.07e-06	8.06e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTT1—kidney cancer	7.07e-06	8.06e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTT1—kidney cancer	7.03e-06	8.01e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ACHE—kidney cancer	7.03e-06	8.01e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SLC5A5—kidney cancer	7.02e-06	8e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA2—kidney cancer	6.94e-06	7.92e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SLC2A1—kidney cancer	6.94e-06	7.91e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ITPR2—kidney cancer	6.92e-06	7.89e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.82e-06	7.77e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CRABP1—kidney cancer	6.79e-06	7.73e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.78e-06	7.73e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALAD—kidney cancer	6.77e-06	7.71e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ITPR2—kidney cancer	6.75e-06	7.7e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SCARB1—kidney cancer	6.69e-06	7.63e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SCARB1—kidney cancer	6.65e-06	7.58e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS1—kidney cancer	6.62e-06	7.55e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.61e-06	7.53e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS1—kidney cancer	6.59e-06	7.51e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PSMD7—kidney cancer	6.5e-06	7.4e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PSMD7—kidney cancer	6.46e-06	7.36e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.46e-06	7.36e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—RAF1—kidney cancer	6.43e-06	7.33e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.38e-06	7.27e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTT1—kidney cancer	6.31e-06	7.19e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ACHE—kidney cancer	6.31e-06	7.19e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ITPR2—kidney cancer	6.31e-06	7.19e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.19e-06	7.06e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PGK1—kidney cancer	6.19e-06	7.06e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ACHE—kidney cancer	6.16e-06	7.02e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTT1—kidney cancer	6.16e-06	7.02e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—BCHE—kidney cancer	6.16e-06	7.02e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—BCHE—kidney cancer	6.12e-06	6.98e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—kidney cancer	6.1e-06	6.95e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.08e-06	6.93e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—LDHB—kidney cancer	6.07e-06	6.92e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SLC5A5—kidney cancer	6.05e-06	6.89e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SCARB1—kidney cancer	5.97e-06	6.81e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS1—kidney cancer	5.91e-06	6.74e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.87e-06	6.7e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SLC2A1—kidney cancer	5.84e-06	6.66e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SCARB1—kidney cancer	5.83e-06	6.64e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.82e-06	6.63e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PSMD7—kidney cancer	5.8e-06	6.61e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTP1—kidney cancer	5.79e-06	6.6e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS1—kidney cancer	5.77e-06	6.58e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL2—kidney cancer	5.77e-06	6.58e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ACHE—kidney cancer	5.75e-06	6.56e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTT1—kidney cancer	5.75e-06	6.56e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.7e-06	6.5e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.67e-06	6.46e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PSMD7—kidney cancer	5.66e-06	6.45e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTP1—kidney cancer	5.66e-06	6.45e-05	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	5.57e-06	6.35e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—BCHE—kidney cancer	5.5e-06	6.26e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—kidney cancer	5.48e-06	6.24e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SCARB1—kidney cancer	5.45e-06	6.21e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.43e-06	6.19e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS1—kidney cancer	5.39e-06	6.14e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—BCHE—kidney cancer	5.36e-06	6.11e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—kidney cancer	5.35e-06	6.1e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTM1—kidney cancer	5.32e-06	6.06e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTEN—kidney cancer	5.32e-06	6.06e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC5A5—kidney cancer	5.3e-06	6.04e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PSMD7—kidney cancer	5.29e-06	6.03e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CA9—kidney cancer	5.26e-06	6e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC2A1—kidney cancer	5.24e-06	5.98e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTM1—kidney cancer	5.2e-06	5.92e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC2A1—kidney cancer	5.12e-06	5.83e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.09e-06	5.8e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—POMC—kidney cancer	5.08e-06	5.79e-05	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CA—kidney cancer	5.07e-06	5.78e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP1A1—kidney cancer	5.04e-06	5.75e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—BCHE—kidney cancer	5.01e-06	5.71e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.97e-06	5.67e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.95e-06	5.64e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.94e-06	5.63e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.93e-06	5.62e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—kidney cancer	4.9e-06	5.59e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTP1—kidney cancer	4.9e-06	5.58e-05	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.88e-06	5.56e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTP1—kidney cancer	4.87e-06	5.55e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.78e-06	5.45e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.64e-06	5.29e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—MAPK3—kidney cancer	4.64e-06	5.29e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—kidney cancer	4.64e-06	5.29e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—kidney cancer	4.61e-06	5.26e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTM1—kidney cancer	4.5e-06	5.13e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTM1—kidney cancer	4.48e-06	5.1e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CRABP1—kidney cancer	4.48e-06	5.1e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.44e-06	5.06e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—MAPK1—kidney cancer	4.41e-06	5.03e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTP1—kidney cancer	4.37e-06	4.98e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTP1—kidney cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.27e-06	4.86e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP1A1—kidney cancer	4.24e-06	4.84e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—kidney cancer	4.17e-06	4.75e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ITPR2—kidney cancer	4.16e-06	4.74e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—kidney cancer	4.14e-06	4.72e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—kidney cancer	4.05e-06	4.62e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.05e-06	4.61e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTM1—kidney cancer	4.02e-06	4.58e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTP1—kidney cancer	3.99e-06	4.54e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTM1—kidney cancer	3.92e-06	4.47e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—kidney cancer	3.83e-06	4.37e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.81e-06	4.34e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ACHE—kidney cancer	3.79e-06	4.32e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTT1—kidney cancer	3.79e-06	4.32e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—kidney cancer	3.77e-06	4.3e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—POMC—kidney cancer	3.76e-06	4.28e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—kidney cancer	3.75e-06	4.28e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP1A1—kidney cancer	3.72e-06	4.24e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—kidney cancer	3.7e-06	4.22e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—POMC—kidney cancer	3.67e-06	4.19e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTM1—kidney cancer	3.66e-06	4.18e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SCARB1—kidney cancer	3.59e-06	4.09e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS1—kidney cancer	3.56e-06	4.05e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTEN—kidney cancer	3.54e-06	4.03e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.51e-06	4e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.49e-06	3.97e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PSMD7—kidney cancer	3.49e-06	3.97e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.47e-06	3.96e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—BCHE—kidney cancer	3.31e-06	3.77e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.26e-06	3.72e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—POMC—kidney cancer	3.18e-06	3.63e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—POMC—kidney cancer	3.16e-06	3.61e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.15e-06	3.59e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.13e-06	3.57e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—kidney cancer	3e-06	3.42e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—kidney cancer	2.93e-06	3.34e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.85e-06	3.25e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—POMC—kidney cancer	2.84e-06	3.24e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—POMC—kidney cancer	2.77e-06	3.16e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTP1—kidney cancer	2.63e-06	3e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTEN—kidney cancer	2.61e-06	2.98e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—POMC—kidney cancer	2.59e-06	2.95e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTEN—kidney cancer	2.56e-06	2.91e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—kidney cancer	2.54e-06	2.89e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—kidney cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.49e-06	2.84e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—kidney cancer	2.49e-06	2.84e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTM1—kidney cancer	2.42e-06	2.75e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.29e-06	2.61e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—kidney cancer	2.27e-06	2.58e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTEN—kidney cancer	2.21e-06	2.52e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—kidney cancer	2.21e-06	2.52e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTEN—kidney cancer	2.2e-06	2.51e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—kidney cancer	2.07e-06	2.35e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTEN—kidney cancer	1.98e-06	2.25e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTEN—kidney cancer	1.93e-06	2.2e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.84e-06	2.1e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTEN—kidney cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—POMC—kidney cancer	1.71e-06	1.95e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—kidney cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.39e-06	1.59e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTEN—kidney cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.38e-07	9.55e-06	CbGpPWpGaD
